WA
The startup develops protein-based therapeutics for immuno-oncology, utilizing a biotechnology platform that targets specific proteins to enhance immune response in cancer treatment. This approach aims to improve patient outcomes by providing more effective therapies tailored to individual tumor profiles.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops protein-based therapeutics for immuno-oncology, utilizing a biotechnology platform that targets specific proteins to enhance immune response in cancer treatment. This approach aims to improve patient outcomes by providing more effective therapies tailored to individual tumor profiles.